Melanoma laboratory tests: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) |
YazanDaaboul (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no laboratory findings associated with the diagnosis of melanoma. | There are no laboratory findings associated with the diagnosis of melanoma. Serum [[lactate dehydrogenase]] (LDH) may be elevated among patients with metastasis. | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
*There are no laboratory findings associated with the diagnosis of melanoma. Measurement of serum LDH may be considered for follow-up among patients who have been diagnosed with stage IB-IV melanoma | *There are no laboratory findings associated with the diagnosis of melanoma. Measurement of serum LDH may be considered for follow-up among patients who have been diagnosed with stage IB-IV melanoma | ||
Revision as of 03:21, 22 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
|
Melanoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Melanoma laboratory tests |
|
Risk calculators and risk factors for Melanoma laboratory tests |
Overview
There are no laboratory findings associated with the diagnosis of melanoma. Serum lactate dehydrogenase (LDH) may be elevated among patients with metastasis.
Laboratory Findings
- There are no laboratory findings associated with the diagnosis of melanoma. Measurement of serum LDH may be considered for follow-up among patients who have been diagnosed with stage IB-IV melanoma
LDH
- Once metastatic melanoma is diagnosed, serum lactate dehydrogenase (LDH) may be helpful for follow-up.
- For patients with stage IB-IV melanoma, measurement of serum LDH may be considered every 6-12 months.